Search all trials

Find therapies in clinical trials near you – page 12

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Prostate cancer

Not recruiting

Registered drugNo placebo

Study on the Effect of Adding Leuprorelin Acetate to Radiotherapy for Patients with Oligo-recurrent Prostate Cancer with Up to 4 Metastases

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Leuprorelin Acetate

Contact Research Centre

Multiple sclerosis

Not recruiting

Registered drugNo placebo

Study on Personalized Dosing of Natalizumab for Patients with Relapsing-Remitting Multiple Sclerosis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Natalizumab

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

Registered drugNo placebo

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Gilteritinib

Contact Research Centre

CDKL5 deficiency disorder

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Fenfluramine Hydrochloride for Patients with CDKL5 Deficiency Disorder

Registered drug

The Netherlands

Participants:0–17 years · 18–64 years
Substances:Fenfluramine Hydrochloride

Contact Research Centre

Staphylococcal bacteraemia

Not recruiting

Registered drugNo placebo

Study on Reducing Antibiotic Duration for Patients with Complicated Staphylococcus aureus Bacteremia Using Cefazolin Sodium, Flucloxacillin Sodium Monohydrate, and Clindamycin

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Cefazolin Sodium

Contact Research Centre

K-ras gene mutation+2

Not recruiting

Registered drugNo placebo

Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years

Contact Research Centre

Burkitt's lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Rituximab with Drug Combination for Patients with Newly Diagnosed High-Risk Burkitt Lymphoma

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study Comparing Naporafenib and Trametinib Combination to Other Therapies for Patients with Previously Treated Unresectable or Metastatic NRAS Mutant Melanoma

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Dacarbazine

Contact Research Centre

Severe myoclonic epilepsy of infancy+1

Not recruiting

Registered drugNo placebo

Long-Term Safety Study of Fenfluramine Hydrochloride for Seizures in Patients with Dravet or Lennox-Gastaut Syndrome

Registered drugNo placebo

The Netherlands

Participants:0–17 years · 18–64 years
Substances:Fenfluramine Hydrochloride

Contact Research Centre

Multiple sclerosis

Not recruiting

Registered drugNo placebo

Study on Personalized Ocrelizumab Dosing for Patients with Relapsing Remitting Multiple Sclerosis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Ocrelizumab

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

InvestigationalNo placebo

Study on the Effects of ALZ-801 in Patients Aged 50-80 with Early Alzheimer's Disease and APOE4 Genotype

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Valiltramiprosate

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

Investigational

Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Enasidenib Mesilate

Contact Research Centre

Find therapies in clinical trials near you – page 12

197 trials match your criteria

Prostate cancer

Study on the Effect of Adding Leuprorelin Acetate to Radiotherapy for Patients with Oligo-recurrent Prostate Cancer with Up to 4 Metastases

Multiple sclerosis

Study on Personalized Dosing of Natalizumab for Patients with Relapsing-Remitting Multiple Sclerosis

Acute myeloid leukaemia+1

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

CDKL5 deficiency disorder

Study on the Effectiveness and Safety of Fenfluramine Hydrochloride for Patients with CDKL5 Deficiency Disorder

Staphylococcal bacteraemia

Study on Reducing Antibiotic Duration for Patients with Complicated Staphylococcus aureus Bacteremia Using Cefazolin Sodium, Flucloxacillin Sodium Monohydrate, and Clindamycin

K-ras gene mutation+2

Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

Burkitt's lymphoma

Study Comparing Rituximab with Drug Combination for Patients with Newly Diagnosed High-Risk Burkitt Lymphoma

Malignant melanoma

Study Comparing Naporafenib and Trametinib Combination to Other Therapies for Patients with Previously Treated Unresectable or Metastatic NRAS Mutant Melanoma

Severe myoclonic epilepsy of infancy+1

Long-Term Safety Study of Fenfluramine Hydrochloride for Seizures in Patients with Dravet or Lennox-Gastaut Syndrome

Multiple sclerosis

Study on Personalized Ocrelizumab Dosing for Patients with Relapsing Remitting Multiple Sclerosis

Dementia Alzheimer's type

Study on the Effects of ALZ-801 in Patients Aged 50-80 with Early Alzheimer's Disease and APOE4 Genotype

Acute myeloid leukaemia+1

Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.